| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/17/2001 | WO2001034847A2 Flow cell for synthesis of arrays of dna probes and the like |
| 05/17/2001 | WO2001034846A2 Direct mapping of dna chips to detector arrays |
| 05/17/2001 | WO2001034845A1 Method for quantitating oligonucleotides |
| 05/17/2001 | WO2001034834A2 Endogenous gene expression assay |
| 05/17/2001 | WO2001034833A2 Regulating endogenous inhibitor at atp synthase |
| 05/17/2001 | WO2001034824A2 Methods and compositions comprising renilla gfp |
| 05/17/2001 | WO2001034806A2 Methods and compositions for screening using diphtheria toxin constructs |
| 05/17/2001 | WO2001034802A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 05/17/2001 | WO2001034800A1 19 human secreted proteins |
| 05/17/2001 | WO2001034799A1 6 human secreted proteins |
| 05/17/2001 | WO2001034794A1 Casb7434, an antigen over-expressed in colon cancer |
| 05/17/2001 | WO2001034789A2 Computational method for inferring elements of gene regulatory network from temporal patterns of gene expression |
| 05/17/2001 | WO2001034788A1 In-vitro assay for assessment of cytotoxicity of a candidate agent |
| 05/17/2001 | WO2001034769A2 24 human secreted proteins |
| 05/17/2001 | WO2001034765A1 Methods and apparatus for the electronic, homogeneous assembly and fabrication of devices |
| 05/17/2001 | WO2001034709A1 Dye labeled imidazoquinoline compounds |
| 05/17/2001 | WO2001034653A2 Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof |
| 05/17/2001 | WO2001034652A1 Antibodies to suberic acid crosslinkers and methods for using the same |
| 05/17/2001 | WO2001034642A2 Control of neisserial membrane synthesis |
| 05/17/2001 | WO2001034640A2 Peptide (virip) which inhibits a circulating virus in humans and the use thereof |
| 05/17/2001 | WO2001034636A1 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 05/17/2001 | WO2001034634A2 Tumor suppressor molecules and methods of use |
| 05/17/2001 | WO2001034629A1 21 human secreted proteins |
| 05/17/2001 | WO2001034623A1 29 human secreted proteins |
| 05/17/2001 | WO2001034621A1 Kringle domain-containing polynucleotides, polypeptides, and antibodies |
| 05/17/2001 | WO2001034302A2 Biochannel assay for hybridization with biomaterial |
| 05/17/2001 | WO2001034292A2 Macroporous media for biological application prepared by freeze drying |
| 05/17/2001 | WO2001034202A2 Depletion of cellular coenzyme-a levels as a means to selectively kill cancer cells |
| 05/17/2001 | WO2001034201A2 Methods for inhibiting neurofibromatosis type 1 (nf1) |
| 05/17/2001 | WO2001034145A1 Treating cancer by increasing intracellular malonyl coa levels |
| 05/17/2001 | WO2001034029A1 Body fluid measuring instrument and body fluid sampler thereof |
| 05/17/2001 | WO2001034024A1 Marker detection method and apparatus to monitor drug compliance |
| 05/17/2001 | WO2001033954A1 Melanocortin-3 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
| 05/17/2001 | WO2001023893A3 Detection of hla-g |
| 05/17/2001 | WO2001020003A3 Variants of the gamma chain of ampk, dna sequences encoding the same, and uses thereof |
| 05/17/2001 | WO2001012598A9 METHODS OF INHIBITING BINDING OF β-SHEET FIBRIL TO RAGE AND CONSEQUENCES THEREOF |
| 05/17/2001 | WO2001011013A3 The interaction of smad6 with hox proteins and uses thereof |
| 05/17/2001 | WO2001007891A3 Miniaturized cell array methods and apparatus for cell-based screening |
| 05/17/2001 | WO2001007607A3 FULL LENGTH cDNA CLONES AND PROTEINS ENCODED THEREBY |
| 05/17/2001 | WO2001007471A9 Cell cycle and proliferation proteins |
| 05/17/2001 | WO2001005427B1 Psca: prostate stem cell antigen and uses thereof |
| 05/17/2001 | WO2001004157A3 NOVEL METHOD AND COMPOSITION FOR INHIBITION OF ANGIOGENESIS USING ANTAGONISTS BASED ON MMP-9 AND β1 INTEGRINS |
| 05/17/2001 | WO2001001120A3 Universal transducer |
| 05/17/2001 | WO2000077505A3 Carbon monoxide sensor |
| 05/17/2001 | WO2000077166A3 Gene expression modulated in gastrointestinal inflammation |
| 05/17/2001 | WO2000076550A3 Carrier-drug conjugate |
| 05/17/2001 | WO2000071710A3 Expression products of genes involved in diseases related to cholesterol metabolism |
| 05/17/2001 | WO2000058729A3 Micromechanical antibody sensor |
| 05/17/2001 | WO2000049038A9 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof |
| 05/17/2001 | WO2000043551A9 Determining viral load in double negative t cells |
| 05/17/2001 | WO2000033077A9 Cell matrix plaques of initial bone formation |
| 05/17/2001 | WO2000024755A9 Ovary-specific genes and proteins |
| 05/17/2001 | WO1999044620A9 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 05/17/2001 | WO1994003601A3 Cloning, expression and uses for neurocan as a chondroitin sulfate proteoglycan |
| 05/17/2001 | US20010001310 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes |
| 05/17/2001 | DE19954934A1 Verfahren zur Solubilisierung von optischen Markern Process for the solubilization of optical markers |
| 05/17/2001 | DE19954783A1 Process for detecting presence of nitrogen and/or carbon from organic substances comprises determining nitrogen and/or carbon content of fraction, measuring using reflection and/or transmission spectroscopy and calibrating |
| 05/17/2001 | DE19952955A1 Verfahren zur Charakterisierung und zur Auftrennung von molekularen Assoziaten A method for characterization and for the separation of molecular associates |
| 05/17/2001 | DE19952911A1 In-situ monitoring of mineral seals, e.g. waste dump linings, comprises measuring impedance over specified region on electrodes inserted, screwed or embedded into seals |
| 05/17/2001 | DE19952725C1 Gasdurchlässige Membran und deren Verwendung zur Steuerung des Gasdurchganges Gas permeable membrane and their use for the control of the gas passage |
| 05/17/2001 | DE19952215A1 Testelement-Analysesystem Test element analysis system |
| 05/17/2001 | DE19949029A1 Verfahren und Vorrichtung zur Charakterisierung einer Kulturflüssigkeit Method and apparatus for characterizing a culture liquid |
| 05/17/2001 | DE10033702A1 Gießvorrichtung Caster |
| 05/17/2001 | DE10004612A1 Measurement head for non-contact measurement of the characteristics of a moving paper/cardboard web has a gas outlet opening for air to flow between the suction foot and the web with a light source and optical signal receiver |
| 05/17/2001 | CA2396626A1 Methods and compositions for screening using diphtheria toxin constructs |
| 05/17/2001 | CA2391369A1 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 05/17/2001 | CA2391366A1 Computational method for inferring elements of gene regulatory network from temporal patterns of gene expression |
| 05/17/2001 | CA2391277A1 Treating cancer by increasing intracellular malonyl coa levels |
| 05/17/2001 | CA2391244A1 Methods for the quantitation of oxidized glutathione |
| 05/17/2001 | CA2391009A1 Biosensing using surface plasmon resonance |
| 05/17/2001 | CA2391004A1 Method for quantitating oligonucleotides |
| 05/17/2001 | CA2390723A1 Melanocortin-3 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
| 05/17/2001 | CA2390696A1 Method of stabilizing a luminescent acridinium compound and composition containing the stabilizer |
| 05/17/2001 | CA2390646A1 Compositions and methods for regulating endogenous inhibitor of atp synthase, including treatment for diabetes |
| 05/17/2001 | CA2390565A1 Macroporous media for biological application prepared by freeze drying |
| 05/17/2001 | CA2390501A1 Depletion of cellular coenzyme-a levels as a means to selectively kill cancer cells |
| 05/17/2001 | CA2390438A1 19 human secreted proteins |
| 05/17/2001 | CA2390375A1 Cell analysis and sorting apparatus for manipulation of cells |
| 05/17/2001 | CA2390374A1 Diagnosis and treatment of malignant neoplasms |
| 05/17/2001 | CA2390163A1 Dye labeled imidazoquinoline compounds |
| 05/17/2001 | CA2390161A1 Methods for identifying and using amyloid-inhibitory compounds |
| 05/17/2001 | CA2390011A1 Methods and compositions comprising renilla gfp |
| 05/17/2001 | CA2389550A1 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 05/17/2001 | CA2389549A1 Biochannel assay for hybridization with biomaterial |
| 05/17/2001 | CA2389330A1 Kringle domain-containing polynucleotides, polypeptides, and antibodies |
| 05/17/2001 | CA2389204A1 Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof |
| 05/17/2001 | CA2388912A1 6 human secreted proteins |
| 05/17/2001 | CA2388343A1 Methods for inhibiting neurofibromatosis type 1 (nf1) |
| 05/17/2001 | CA2388034A1 Direct mapping of dna chips to detector arrays |
| 05/17/2001 | CA2388019A1 24 human secreted proteins |
| 05/17/2001 | CA2388008A1 29 human secreted proteins |
| 05/17/2001 | CA2387959A1 21 human secreted proteins |
| 05/17/2001 | CA2386866A1 Tumor suppressor molecules and methods of use |
| 05/17/2001 | CA2360206A1 Method for rapidly determining the presence of malondialdehyde (mda) in urine, in food and cosmetic products |
| 05/17/2001 | CA2359978A1 Method and device for determining the threshold of heavy fraction deposit contained in a liquid hydrocarbon fluid |
| 05/17/2001 | CA2325226A1 Use of polypeptides or nucleic acids encoding these for the diagnosis or treatment of skin disorders, and their use for the identification of pharmacologically active substances |
| 05/16/2001 | EP1099949A1 Device for measuring gases with odors |
| 05/16/2001 | EP1099765A1 Quantitative determination method of mannose and reagent therefor |
| 05/16/2001 | EP1099764A2 Sterilization indicator using DNA specific dyes |
| 05/16/2001 | EP1099506A1 Method and device for measuring process parameters of a material machining process |